Phase II study of neoadjuvant therapy with epirubicin and docetaxel for women with locally advanced breast cancer.

被引：0
|
作者：
Holter, JL
Tfayli, A
Venkattapa, S
Bova, A
Howard, O
机构：
[1] Univ Oklahoma, Moore, OK USA
[2] Univ Oklahoma, Oklahoma City, OK USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：98S / 98S
页数：1
相关论文
共 50 条
  • [11] Phase II study of combined docetaxel, epirubicin, and cyclophosphamide as a neoadjuvant chemotherapy regimen in patients with locally advanced breast cancer in a single institution
    Yao, X.
    Hosenpud, J. R.
    Chitambar, C. R.
    Charlson, J. A.
    Cheng, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [12] Docetaxel and epirubicin as neoadjuvant chemotherapy (CT) in locally advanced breast cancer (LABC).
    Alkhatib, F
    Alawadi, S
    Grohn, P
    Motawy, M
    Fayaz, S
    Patel, J
    Attia, N
    Trad, D
    Delvadia, M
    ANNALS OF ONCOLOGY, 2000, 11 : 21 - 22
  • [13] A phase II trial of Neoadjuvant docetaxel and capecitabine for locally advanced breast cancer
    Lebowitz, PF
    Eng-Wong, J
    Swain, SM
    Berman, A
    Merino, MJ
    Chow, CK
    Venzon, D
    Zia, F
    Danforth, D
    Liu, E
    Zujewski, J
    CLINICAL CANCER RESEARCH, 2004, 10 (20) : 6764 - 6769
  • [14] Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
    Yen-Shen Lu
    Dar-Ren Chen
    Ling-Min Tseng
    Dah-Cherng Yeh
    Shou-Tung Chen
    Chia-Ming Hsieh
    Hwei-Chung Wang
    Hsien-Tang Yeh
    Sung-Hsin Kuo
    Chiun-Sheng Huang
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1257 - 1263
  • [15] Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
    Lu, Yen-Shen
    Chen, Dar-Ren
    Tseng, Ling-Min
    Yeh, Dah-Cherng
    Chen, Shou-Tung
    Hsieh, Chia-Ming
    Wang, Hwei-Chung
    Yeh, Hsien-Tang
    Kuo, Sung-Hsin
    Huang, Chiun-Sheng
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1257 - 1263
  • [16] A PHASE II NEOADJUVANT TRIAL OF GENEXOL® (PACLITAXEL) AND EPIRUBICIN IN LOCALLY ADVANCED BREAST CANCER
    Kim, J.
    Lee, J.
    Ahn, B.
    Jeong, H.
    Byun, W.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1060 - 1060
  • [17] Epirubicin/cyclophosphamide followed by docetaxel as the primary systemic therapy for locally advanced breast cancer: The final analysis of a phase II study
    Hirano, Akira
    Kamimura, Mari
    Ogura, Kaoru
    Hattori, Akinori
    Okubo, Fumie
    Inoue, Hiroaki
    Kinoshita, Jun
    Fujibayashi, Mariko
    Shimizu, Tadao
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [18] A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer
    Villman, Kenneth
    Ohd, John F.
    Lidbrink, Elisabet
    Malmberg, Lena
    Lindh, Birgitta
    Blomqvist, Carl
    Nordgren, Hans
    Bergh, Jonas
    Bergstrom, Daniel
    Ahlgren, Johan
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (07) : 1153 - 1160
  • [19] Combination of vinorelbine, epirubicin, and cyclophosphamide as Neoadjuvant chemotherapy for locally advanced breast cancer - Phase II study
    Braud, AC
    Levy, E
    Feuilhade, F
    Otmezguine, Y
    Calitchi, E
    Kirova, Y
    Le Bourgeois, JP
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (03): : 303 - 307
  • [20] Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer
    E. Espinosa
    S. Morales
    P. Borrega
    A. Casas
    C. Madroñal
    I. Machengs
    J. A. Illarramendi
    J. Lizón
    J. A. Moreno
    J. Belón
    J. Janáriz
    M. de la Puente
    T. Checa
    J. R. Mel
    M. González Barón
    Cancer Chemotherapy and Pharmacology, 2004, 54 : 546 - 552
12345